Biography of Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life
Paolo De Martin's presentation at the Pacific Insurance Conference 2017
SCOR is driven to see its clients succeed and puts all its passion and energy into unlocking value for them.
Antimicrobial resistance is a global concern that can jeopardize the treatment of infectious diseases.
During his presentation at the SCOR Conference 2017, titled “Transhumanism: the future impact of advanced technologies on society and on the insurance industry”, Laurent Alexandre, CEO of DNA Vision, warned insurers o
On 23 November 2017, the Channel Syndicate, SCOR’s Lloyd’s Syndicate, was distinguished twice at the 2017 Insurance Day London Market Awards, during a ceremony at the Hilton London Bankside.
On 24 October 2017, SCOR created a Corporate Social Responsibility committee in order to leverage on the pivotal role of boards in terms of ensuring that corporate strategies are consistent with a company’s long-term
Autonomous machines are an increasingly present feature in business and in everyday life.
Although the prevalence of heart valve diseases is low in the general population - around 2.5% - it is much higher in patients aged 75 years and older, reaching 10% to 15%.
SCOR Global Life announces the creation of a new Executive Leadership Team.
Chairman & CEO of SCOR, Denis Kessler publishes an editorial piece in the French weekly Challenges, covering economic, political and financial current events in France and worldwide.